参考文献/References:
[1] Leszek J,Trypka E,Tarasov VV,et al.Type 3 diabetes mellitus: a novel implication of Alzheimers disease[J].Curr Top Med Chem,2017,17(12):1331-1335.DOI:10.2174/1568026617666170103163403.
[2] Rani L,Mittal J,Mallajosyula SS.Effect of phosphorylation and O-GlcNAcylation on Proline-Rich domains of Tau[J].J Phys Chem B,2020,124(10):1909-1918.DOI:10.1021/acs.jpcb.9b11720.
[3] Grillo CA,Piroli GG,Lawrence RC,et al.Hippocampal insulin resistance impairs spatial learning and synaptic plasticity[J].Diabetes,2015,64(11):3927-3936.DOI:10.2337/db15-0596.
[4] Grillo CA,Woodruff JL,Macht VA,et al.Insulin resistance and hippocampal dysfunction:disentangling peripheral and brain causes from consequences[J].Exp Neurol,2019,318:71-77.DOI:10.1016/j.expneurol.2019.04.012.
[5] Craft S,Raman R,Chow TW,et al.Safety,efficacy,and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia:a randomized clinical trial[J].JAMA Neurol,2020,77(9):1099-1109.DOI:10.1001/jamaneurol.2020.1840.
[6] Mustapic M,Tran J,Craft S,et al.Extracellular vesicle biomarkers track cognitive changes following intranasal insulin in Alzheimer's Disease[J].J Alzheimers Dis,2019,69(2):489-498.DOI:10.3233/JAD-180578.
[7] Zhao N,Liu CC,Van Ingelgom AJ,et al.Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes[J].Neuron,2017,96(1):115-129.e5.DOI:10.1016/j.neuron.2017.09.003.
[8] 朱丹,蔡可英,曹萌,等.胰岛素原稳态与胰岛β细胞功能[J].内分泌与代谢疾病,2015,35(2):110-113.DOI:10.3760/cma.j.issn.1673-4157.2015.02.010.
[9] Arunagiri A,Haataja L,Pottekat A,et al.Proinsulin misfolding is an early event in the progression to type 2 diabetes[J].Elife,2019,8:e44532.DOI:10.7554/eLife.44532.
[10] Lee HK,Kwon B,Lemere CA,et al.mTORC2(Rictor)in Alzheimer's Disease and reversal of Amyloid-β expression-induced insulin resistance and toxicity in rat primary cortical neurons[J].J Alzheimers Dis,2017,56(3):1015-1036.DOI:10.3233/JAD-161029.
[11] He YX,Shen QY,Tian JH,et al.Zonisamide ameliorates cognitive impairment by inhibiting ER stress in a mouse model of type 2 diabetes mellitus[J].Front Aging Neurosci,2020,12:192.DOI:10.3389/fnagi.2020.00192.
[12] De Felice FG,Lourenco MV,Ferreira ST.How does brain insulin resistance develop in Alzheimer's disease? [J].Alzheimers Dement,2014,10(1Suppl):S26-32.DOI:10.1016/j.jalz.2013.12.004.
[13] Liu S,Li X,Yang J,et al.Misfolded proinsulin impairs processing of precursor of insulin receptor and insulin signaling in β cells[J].FASEB J,2019,33(10):11338-11348.DOI:10.1096/fj.201900442R.
[14] De Felice FG,Benedict C.A key role of insulin receptors in memory[J].Diabetes,2015,64(11):3653-3655.DOI:10.2337/dbi15-0011.
[15] Folch J,Ettcheto M,Busquets O,et al.The implication of the brain insulin receptor in late onset Alzheimer's disease dementia[J].Pharmaceuticals(Basel),2018,11(1):11.DOI:10.3390/ph11010011.
[16] Ren B,Zhang Y,Zhang M,et al.Fundamentals of cross-seeding of amyloid proteins:an introduction[J].J Mater Chem B,2019,7(46):7267-7282.DOI:10.1039/c9tb01871a.
[17] de la Monte SM.Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease[J].Curr Alzheimer Res,2012,9(1):35-66.DOI:10.2174/156720512799015037.
[18] Mukherjee A,Morales-Scheihing D,Butler PC,et al.Type 2 diabetes as a protein misfolding disease[J].Trends Mol Med,2015,21(7):439-449.DOI:10.1016/j.molmed.2015.04.00
[19] Di Domenico F,Barone E,Perluigi M,et al.The triangle of death in Alzheimer's disease brain:the aberrant cross-talk among energy metabolism,mammalian target of rapamycin signaling,and protein homeostasis revealed by redox proteomics[J].Antioxid Redox Signal,2017,26(8):364-387.DOI:10.1089/ars.2016.6759.
相似文献/References:
[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(05):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(05):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性
血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(05):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(05):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平
及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(05):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(05):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病
患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]